Risks and benefits of TIPS in HCC and other liver malignancies: a literature review
Abstract Background Transjugular intrahepatic portosystemic shunt (TIPS) is a well-validated treatment option for clinically significant portal hypertension (CSPH) in the context of liver cirrhosis. Its high efficacy and safety in the management of treatment-refractory ascites and variceal bleeding...
Main Authors: | Anna Fichtl, Thomas Seufferlein, Eugen Zizer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-023-03047-0 |
Similar Items
-
A new and improved transjugular intrahepatic portosystemic shunt (TIPS) stent graft: Controlled expansion
by: Harry Trieu, et al.
Published: (2018-04-01) -
Thirty years' transjugular intrahepatic portosystemic stent‐shunt (TIPS) in China: Opportunities and challenges
by: Haibo Shao, et al.
Published: (2022-06-01) -
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
by: Hae Lim Lee, et al.
Published: (2022-04-01) -
Rethink Your Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pre-TIPS Infection Predicts Post-TIPS Infection and Post-TIPS Portosystemic Encephalopathy
by: Jenna E. Koblinski, et al.
Published: (2020-06-01) -
Trans-splenic Approach for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation in Patients with Portal Vein Thrombosis
by: Maryam Boumezrag, et al.
Published: (2024-07-01)